Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data
Obesity · 2026
DOI: 10.1002/oby.70180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Jordan H Mallette und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, USA. Hauptthemen laut MEDLINE: Black or African American, Glucagon-Like Peptide-1 Receptor Agonists, Obesity. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Objective
This study examined racial differences in weight loss and clinical response to glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) therapy among adults with obesity using real‐world data.
Methods
We retrospectively analyzed our institution's Research Data Warehouse (RDW) containing deidentified data from electronic health records (EHRs) from adults aged 18 years and older. EHR data from the University of Mississippi Medical Center RDW were analyzed for 7214 adults (2182 White; 5032 Black) prescribed injectable GLP‐1RA between 2015 and 2025. Inclusion criteria were BMI ≥ 30 kg/m 2 and ≥ 1 GLP‐1RA. Longitudinal changes in patient data were modeled using generalized additive mixed models.
Results
At 2.5 years, White individuals experienced significantly greater body weight loss than Black individuals: −7.1% (95% CI −8.0%, −6.2%) versus −4.9% (95% CI −5.4%, −4.3%), as well as significantly larger reductions in estimated glomerular filtration rate, systolic blood pressure, and HbA1c. Semaglutide and tirzepatide were associated with the greatest improvements. Renal function decline was attenuated in both groups after therapy.
Conclusions
In a large, diverse EHR cohort, GLP‐1RA therapy was associated with significant weight, glycemic, and renal benefits that were attenuated in Black adults. These findings highlight the urgent need to understand mechanisms contributing to variable GLP‐1RA outcomes among different populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi, USA.
- Department of Data Science, University of Mississippi Medical Center, Jackson, Mississippi, USA.
ORCID-Profile: Seth T Lirette
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities
- National Institute of General Medical Sciences
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Mallette, J. H., Speed, J. S., Lirette, S. T., Moore, D., & Clemmer, J. S. (2026). Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data. Obesity. https://doi.org/10.1002/oby.70180
Vancouver
Mallette JH, Speed JS, Lirette ST, Moore D, Clemmer JS. Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data. Obesity. 2026. doi:10.1002/oby.70180
BibTeX
@article{Mallette2026,
author = {Mallette, Jordan H and Speed, Joshua S and Lirette, Seth T and Moore, Daniel and Clemmer, John S},
title = {Responses to GLP ‐ 1RA in White and Black Adults With Obesity: Insights From Generalized Additive Mixed Models of EHR Data},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70180}
}
EUVIMED